Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 283,600 shares, an increase of 159.2% from the December 31st total of 109,400 shares. Based on an average trading volume of 739,800 shares, the short-interest ratio is presently 0.4 days. Approximately 23.8% of the company’s shares are sold short.
Autonomix Medical Stock Performance
NASDAQ:AMIX opened at $2.98 on Wednesday. The stock has a market cap of $3.43 million and a P/E ratio of -0.19. The firm’s fifty day simple moving average is $4.20 and its 200 day simple moving average is $10.81. Autonomix Medical has a twelve month low of $2.55 and a twelve month high of $152.00. The company has a quick ratio of 4.26, a current ratio of 4.26 and a debt-to-equity ratio of 0.36.
Autonomix Medical (NASDAQ:AMIX – Get Free Report) last released its quarterly earnings results on Friday, November 8th. The company reported ($2.47) earnings per share for the quarter. As a group, research analysts predict that Autonomix Medical will post -10 EPS for the current year.
About Autonomix Medical
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Featured Articles
- Five stocks we like better than Autonomix Medical
- How to Invest in the Best Canadian Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Are Penny Stocks a Good Fit for Your Portfolio?
- What Does the Future Hold for Eli Lilly?
- Breakout Stocks: What They Are and How to Identify Them
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.